Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin
Go back to Palvella Therapeutics Announces Issuance of European Patent Covering Anhydrous Compositions of Rapamycin| (NASDAQ: PVLA) | Delayed: 146.76 +8.50 (6.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $138.26 | 52 Week High | $ | |||
| Open | $138.58 | 52 Week Low | $ | |||
| Day High | $146.88 | P/E | N/A | |||
| Day Low | $136.77 | EPS | $ | |||
| Volume | 321,856 | |||||

